XOMA Q1 2023 revenue drops to $0.4M; net loss widens to $9.8M; acquires IXINITY stream

XOMA Royalty Corp

2023-Q1 EPS reported -$0.98 revenue$437,000

Total revenue of $0.4M in Q1 2023 vs $3.1M in Q1 2022; no milestone revenue recognized.
Net loss of $9.8M ($2.3M loss in Q1 2022) including $4.1M arbitration settlement costs.
Cash and equivalents $44.3M at March 31, 2023; no debt; operating cash burn $4.9M.
Acquired IXINITY commercial payment stream from Aptevo in March 2023; payments to begin Q2 2023.
Received second commercial payment from Roche for Vabysmo (faricimab) in February 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

XOMA Royalty Corp reported first quarter of 2023 results: revenue $0.4 million, net income $9.8 million.

Period: first quarter of 2023
Revenue: $0.4 million
Net income: $9.8 million
Result: reported results

Exact text from the filing

XOMA recorded total revenues of $0.4 million for the first quarter of 2023, compared with $3.1 million in the first quarter of 2022.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

XOMA Royalty Corp filing history →

Source: SEC EDGAR

accession 0001193125-23-138911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.